-
Integrating iPSC-CM Transcriptomics and Cardiac Function
2026-09-24
This study combines concentration-response measurements of cardiac function and gene expression in human iPSC-derived cardiomyocytes to screen 464 chemicals and compare their points of departure for risk prioritization. The results show that transcriptomic and functional data can provide complementary hazard information, while producing broadly similar bioactivity-to-exposure-based risk characterizations.
-
Bestatin-Derived Selective Inhibitors of IRAP
2026-09-23
The study reports a stereoselective route to functionalized bestatin derivatives and uses P1 side-chain changes to identify a cell-active, low-nanomolar IRAP inhibitor with more than 120-fold selectivity over related enzymes. Structural analyses point to the GAMEN loop as an important, previously underappreciated contributor to inhibitor potency and selectivity.
-
Triterpene Prodrug Enables Targeted OSCC Therapy
2026-09-23
This 2024 ACS Applied Materials & Interfaces study developed a carrier-free, self-assembled prodrug from glycyrrhetinic acid and ginsenoside Rh2 for oral squamous cell carcinoma. Its thioketal-linked design uses tumor-associated reactive oxygen species to release the active triterpenes while glycyrrhetinic acid amplifies oxidative stress, creating a self-boosting mechanism that may improve therapeutic selectivity without a conventional nanocarrier.
-
EDC.HCl: Practical Coupling Workflow Guide
2026-09-22
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for in vitro amide bond formation in peptide synthesis, bioconjugation, and related workflows. It is intended for controlled laboratory use only; the supplied dossier reports no in vivo or clinical data.
-
Short-Scale BIR in Mouse Oocytes
2026-09-22
The reference study identifies a short-scale form of break-induced replication in fully grown mouse oocytes and shows that DNA double-strand breaks can promote further damage through Rad51- and DNA synthesis-dependent mechanisms. Its inhibitor-based design links EdU-positive synthesis with damage-marker amplification, providing a framework for studying genome instability during mammalian gametogenesis.
-
DiscoveryProbe Protease Inhibitor Library Workflow
2026-09-21
Build a mechanism-first screening workflow around 825 pre-dissolved compounds for biochemical, cellular, and high-content protease studies. The approach connects protease inhibition with pathway validation, apoptosis assay design, and cancer research while clearly separating exploratory hits from disease-specific evidence.
-
HATU: Mechanism, Peptide Coupling, and Workflow
2026-09-21
HATU is a high-efficiency peptide coupling reagent for carboxylic acid activation and amide or ester formation. Its OAt-active-ester pathway, compatibility with DIPEA and DMF, and defined storage and solubility profile make it useful for peptide synthesis chemistry and medicinal chemistry workflows.
-
NF 449: Reading P2X1 Data Without Overreach
2026-09-20
NF 449 is a potent purinergic receptor antagonist for dissecting P2X1-dependent platelet signaling. This article explains how its original Gαs pharmacology changes the interpretation of platelet assays and supports more rigorous antithrombotic agent research.
-
Dabigatran Etexilate: Translational Thrombin Insight
2026-09-19
A mechanistic and strategic guide to using Dabigatran etexilate as a direct thrombin inhibitor in coagulation, atrial fibrillation, and translational research.
-
Sodium Salicylate as an NF-κB Inhibitor
2026-09-18
Sodium salicylate is a research-grade NF-κB inhibitor used to study inflammatory signaling and downstream oxidative-stress phenotypes. Its defined formula, solvent-specific solubility, refrigerated storage specification, and research-only status support controlled assay design, but the compound has not been validated as the active agent in the cited pancreatic nanomedicine study.
-
Ibrutinib, CSK Inhibition, and Atrial Fibrillation
2026-09-18
This study identifies inhibition of C-terminal Src kinase (CSK), rather than Bruton tyrosine kinase (BTK) blockade itself, as the strongest mechanistic explanation for ibrutinib-associated atrial fibrillation. By combining mouse electrophysiology, chemoproteomics, genetic models, pharmacology, and pharmacovigilance, the authors connect off-target kinase activity with electrical, structural, and inflammatory remodeling.
-
HATU Workflows for Peptide Coupling and Inhibitor Design
2026-09-17
HATU combines rapid carboxylic acid activation with practical amide and ester formation, making it useful for peptide synthesis chemistry and medicinal chemistry libraries. This guide connects a controlled HATU workflow with the structure-guided inhibitor strategy reported for IRAP and ERAP enzymes, including assay-ready purification and troubleshooting.
-
R1078 OX40L mRNA: Assay Design Insights
2026-09-17
EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag) supports a layered approach to studying OX40L-mediated immune co-stimulation. This article translates mRNA dendritic-cell evidence into practical controls for expression, ligand display, receptor engagement, and T-cell function without overstating clinical relevance.
-
Cell lysis buffer for WB and IP: CAF workflow
2026-09-16
Build a reproducible workflow for protein extraction, Western blotting, and co-immunoprecipitation in cancer-associated fibroblast studies. This guide shows how a non-denaturing formulation supports ANGPTL4–IQGAP1 pathway analysis while preserving phosphoproteins and native protein interactions.
-
TCEP Hydrochloride for Protein Workflow Optimization
2026-09-16
TCEP hydrochloride provides odorless, water-compatible disulfide reduction for protein digestion, structural analysis, and redox assays. This practical guide connects reduction chemistry with SPRTN–DNA-protein crosslink research while showing where TCEP helps, where it can interfere, and how to optimize each workflow.